Presentation is loading. Please wait.

Presentation is loading. Please wait.

eHIVQUAL 2013 Adult Review: Overview and New Features

Similar presentations

Presentation on theme: "eHIVQUAL 2013 Adult Review: Overview and New Features"— Presentation transcript:

1 eHIVQUAL 2013 Adult Review: Overview and New Features
Date: Tuesday, June 24, 2014 Time: 12:30 to 1:30 P.M. EDT Audio conference information 1. Provide your number when you join the meeting to receive a call back. Alternatively, you can call one of the following numbers: Local: Toll Free: Alternate Toll Free - (For callers not able to call the 844 Toll Free Number): 2. Follow the instructions that you hear on the phone. Cisco Unified MeetingPlace meeting ID: Cisco Unified MeetingPlace profile number for meeting host: For assistance 1. Go to 2. On the left navigation bar, click "Support".

2 Survey Questions New v. experienced users Role NYS v. other
Director Coordinator Security Coordinator NYS v. other Primary objective “Look and feel” of new version Sampling Indicator data entry Data import Reporting features

3 Sampling/Eligibility
Up to three review “buckets” Core review no longer requires visit in each half of the year Optional sampling of supplemental “two-visit” patients Robust sample that is compatible with previous reviews Three types of new patients Newly diagnosed Other new to clinic Newly reengaged Don’t eliminate new patients from core review (or two-visit review)! Web-based sampling tool:

4 Sampling (continued)


6 Import Options Excel files can now be used instead of XML (but XML still supported) Updated documentation Data dictionary Data import guide Sample files Import data after establishing review parameters but before keying in any other patient data One (and only one) import per review “bucket” Besides essential patient identifying information, you can import as many or as few fields as desired/available Examine the imported data Additional information can then be entered “by hand”

7 Import Options (continued)

8 Clinical Indicators: Eliminations
Dropped Indicators Adherence Assessment Health Literacy Screening Hypertension Screening & Management Influenza Vaccination Latent TB Infection Screening Lipid Screening MAC Prophylaxis Oral Health Exam Patient Education Prevention Education Urinalysis

9 Clinical Indicators: Retained & Revised
Retained Indicators ARV Medications Colon Cancer Screening Digital Rectal Exam Gynecology Care – Pap Test Latent TB Infection Screening Mammography Mental Health Screening PCP Prophylaxis Tobacco Use Screening Updated Indicators Anal Pap Smear Baseline Resistance Care Coordination Clinical Visits Colon Cancer Screening Hepatitis C Screening HIV Monitoring Sexual History Taking STI Testing Substance Use Screening

10 Required Indicators Vary by Review Type

11 Patient Profile

12 Reports Default is to run seamlessly across concurrent reviews
Can be filtered in many ways, including patient sample Can and should be exported and shared with your team New and updated reports Expanded set of dashboards Additional patient-level reporting Expanded viral load suppression and patient retention reporting

13 (And…longitudinal reports coming soon!)
49 CLINICAL REPORTS Within the 10 categories of reports I mentioned, there are 49 reports based on the clinical information collected in eHIVQUAL. Following this slide I’m going to briefly spotlight ten of them, but just wanted to give the group a sense of how many we have developed for use. Again, longitudinal reports, allowing you to compare your data between the years you have submitted eHIVQUAL data, are in development and should be available soon. Before I begin showing the reports, I also wanted to add a quick disclaimer that these are mockups of the reports we sent to our programmer, but the will look very similar to what you will see when you have real data. (And…longitudinal reports coming soon!)

14 HIVQUAL DASHBOARD This is the updated HIVQUAL Dashboard. It is comprised of six sections each highlighting clinical areas of importance – these are the retention indicators, the viral load suppression, ART therapy, and baseline resistance test indicators, a Sexually Transmitted Infections section, a Hepatitis C section, smoking cessation, diabetes screening, and cervical pap indicators, and results from the mental health screening indicator.

15 EXECUTIVE DASHBOARD New this year we also have an executive dashboard. This features your overall clinic retention score, followed by a facility level “continuum of care” depicted numerically and graphically – highlighting your HIV caseload on ART, those retained in care, those suppressed at last viral load, and those always suppressed.

As many of you will remember discussing, our revised Viral Load Suppression indicators will allow us to report scores by threshold. In this table, you can see a breakdown of your scores on last Viral Load, and always suppressed, by <20 copies/mL, <50 copies/mL, <200 copies/mL, and finally < the level of detectability for the assay used for each patient. Underneath, there is also a graph depicting your viral load results on last viral load.

17 RETENTION DASHBOARD Another new report is the “Retention Dashboard.” Although we include the filters in the report generator I described earlier, in this report we highlight your scores on the retention score in a variety of ways – by gender, by risk factor, by language, by housing status, by race, and by age. There is a companion report for your Viral Load Suppression scores as well.

This is another new report with a series of pre-selected filters, and allows you to see pie charts of some of your patient characteristics, including Gender, Race, Risk Factor, and Age.

As many of you remember our Colon Cancer Screening indicator has been revised to now include flexible sigmoidoscopy and fecal occult blood testing as additional screening options, and the report has been updated to reflect this. The graph breaks down your screening results by age group, and the report also features how many patients who received a positive screening from one of the newly added options received a follow-up colonoscopy within 60 days.

Finally, here is the revised diabetes screening and management report. Those of you here will remember our long discussion to change the indicator eligibility for screening to patients with a random blood sugar >100 during the review period, and you will also notice the report includes HbA1c results among existing diabetic patients, a new feature this year. Given emerging research discussed in this committee which suggests Hemoglobin A1c in HIV patients is an underestimate, the report also identifies patients with a result greater than 5.8 as compared to 6.5 the typical cutoff. I’ll now turn it over to her, and ask that you listen to her slide briefly before providing any feedback or asking questions.

21 Data Submission and Beyond…
NYS deadline is 8/22/2014 Run validation reports! NYS submissions will require director’s “signature” and feedback on quality improvement plans Benchmark Report(s)

Download ppt "eHIVQUAL 2013 Adult Review: Overview and New Features"

Similar presentations

Ads by Google